Raised soluble P-selectin moderately accelerates atherosclerotic plaque progression.

PLoS One · 2014 · PMC4028245 · PMID 24846287

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Figure 3 shows a trend for an increase in plaque CD45 + leukocytes after 8 weeks of sP-selectin treatment which became highly significant at 16 weeks.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.